Catherine Novack
Stock Analyst at Jones Trading
(0)
# 4926
Out of 5,298 analysts
21
Total ratings
16.67%
Success rate
-34.02%
Average return
Main Sectors:
Top Industries:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
PVLA Palvella Therapeutic... | Initiates Coverage On: Buy | 45 | 23.75 | 89.47% | 1 | Mar 25, 2025 | |
PRQR ProQR Therapeutics | Initiates Coverage On: Buy | 11 | 1.18 | 832.2% | 1 | Feb 12, 2025 | |
KRRO Korro Bio | Initiates Coverage On: Buy | 130 | 14.3 | 809.09% | 1 | Nov 18, 2024 | |
CAPR Capricor Therapeutic... | Initiates Coverage On: Buy | 40 | 9.07 | 341.01% | 1 | Nov 18, 2024 | |
EQ Equillium | Downgrades: Hold | n/a | n/a | n/a | 1 | Nov 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Oct 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 12 16 | 6.01 | 166.22% | 2 | Sep 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 14 | 1.96 | 614.29% | 1 | Sep 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 5 13 | 2.9 | 348.28% | 2 | Aug 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 8 | 1.69 | 373.37% | 1 | May 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 2.53 | 295.26% | 1 | Apr 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 7 10 | 1.19 | 740.34% | 1 | Mar 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 22 | 1.79 | 1129.05% | 1 | Feb 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Oct 5, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 160 | 2.58 | 6101.55% | 1 | Jul 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 11 | n/a | n/a | 1 | Mar 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 25 | n/a | n/a | 1 | Dec 2, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 45 | n/a | n/a | 1 | Oct 4, 2021 |